Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 217

1.
2.

miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer.

Reis ST, Pontes-Junior J, Antunes AA, Dall'Oglio MF, Dip N, Passerotti CC, Rossini GA, Morais DR, Nesrallah AJ, Piantino C, Srougi M, Leite KR.

BMC Urol. 2012 May 29;12:14. doi: 10.1186/1471-2490-12-14.

3.

Low expression of RECK indicates a shorter survival for patients with invasive breast cancer.

Zhang Y, Cheng S, Zhang G, Ma W, Liu Y, Zhao R, Zhang Q, Pang D.

Cancer Sci. 2012 Jun;103(6):1084-9. doi: 10.1111/j.1349-7006.2012.02265.x. Epub 2012 Apr 19.

4.

Role of serum VEGFA, TIMP2, MMP2 and MMP9 in monitoring response to adjuvant radiochemotherapy in patients with primary cervical cancer--results of a companion protocol of the randomized NOGGO-AGO phase III clinical trial.

Braicu EI, Gasimli K, Richter R, Nassir M, Kümmel S, Blohmer JU, Yalcinkaya I, Chekerov R, Ignat I, Ionescu A, Mentze M, Fotopoulou C, Pop C, Lichtenegger W, Sehouli J; Tumor Bank Ovarian Cancer (TOC); German North Eastern Society for Gynecological Oncology (NOGGO).

Anticancer Res. 2014 Jan;34(1):385-91.

PMID:
24403492
5.

Expression of reversion-inducing cysteine-rich protein with kazal motifs and matrix metalloproteinase 9 in middle ear squamous cell carcinoma.

Liu X, Wang W, Chen J, Chen C, Zhou J, Cao L.

ORL J Otorhinolaryngol Relat Spec. 2012;74(1):16-21. doi: 10.1159/000334243. Epub 2011 Dec 16.

PMID:
22178867
6.

MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma.

Wang N, Zhang CQ, He JH, Duan XF, Wang YY, Ji X, Zang WQ, Li M, Ma YY, Wang T, Zhao GQ.

Dig Dis Sci. 2013 Jul;58(7):1863-70. doi: 10.1007/s10620-013-2612-2. Epub 2013 Mar 17.

PMID:
23504349
7.

Relationship between matrix metalloproteinase 2 and lung cancer progression.

Guo CB, Wang S, Deng C, Zhang DL, Wang FL, Jin XQ.

Mol Diagn Ther. 2007;11(3):183-92.

PMID:
17570740
8.

Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.

Wittschieber D, Stenzinger A, Klauschen F, Stephan C, Jung K, Erbersdobler A, Rabien A.

Pathobiology. 2011;78(3):123-31. doi: 10.1159/000323563. Epub 2011 May 26.

PMID:
21613799
9.

HPV16 oncoproteins induce MMPs/RECK-TIMP-2 imbalance in primary keratinocytes: possible implications in cervical carcinogenesis.

Cardeal LB, Boccardo E, Termini L, Rabachini T, Andreoli MA, di Loreto C, Longatto Filho A, Villa LL, Maria-Engler SS.

PLoS One. 2012;7(3):e33585. doi: 10.1371/journal.pone.0033585. Epub 2012 Mar 16.

10.

Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication.

Yu W, Liu J, Xiong X, Ai Y, Wang H.

Pathol Res Pract. 2009;205(10):709-15. doi: 10.1016/j.prp.2009.05.010. Epub 2009 Jun 21.

PMID:
19541433
11.

Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.

Luo M, Shen D, Wang W, Xian J.

Int J Clin Exp Pathol. 2015 May 1;8(5):5542-8. eCollection 2015.

12.

MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.

Lin RJ, Xiao DW, Liao LD, Chen T, Xie ZF, Huang WZ, Wang WS, Jiang TF, Wu BL, Li EM, Xu LY.

J Surg Oncol. 2012 Feb;105(2):175-82. doi: 10.1002/jso.22066. Epub 2011 Aug 22.

PMID:
21882196
13.

Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis.

Li JY, Zhang Y, Zhang WH, Jia S, Kang Y, Tian R.

Asian Pac J Cancer Prev. 2013;14(3):1715-20.

14.

Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.

Watari H, Ohta Y, Hassan MK, Xiong Y, Tanaka S, Sakuragi N.

Gynecol Oncol. 2008 Mar;108(3):527-32. doi: 10.1016/j.ygyno.2007.11.026. Epub 2008 Jan 4.

PMID:
18177691
15.

Clinical significance of Wnt-11 and squamous cell carcinoma antigen expression in cervical cancer.

Wei H, Wang N, Zhang Y, Wang S, Pang X, Zhang J, Luo Q, Su Y, Zhang S.

Med Oncol. 2014 May;31(5):933. doi: 10.1007/s12032-014-0933-4. Epub 2014 Apr 16.

PMID:
24737009
16.

MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients.

Hafez MM, Hassan ZK, Zekri AR, Gaber AA, Al Rejaie SS, Sayed-Ahmed MM, Al Shabanah O.

Asian Pac J Cancer Prev. 2012;13(2):591-8.

17.

Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis.

Zheng HC, Takahashi H, Murai Y, Cui ZG, Nomoto K, Miwa S, Tsuneyama K, Takano Y.

Br J Cancer. 2006 Nov 20;95(10):1371-8. Epub 2006 Oct 31.

18.

Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.

Liu J, Ping W, Zu Y, Sun W.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):6040-7. eCollection 2014.

19.
20.

Clinical significance of matrix metalloproteinase-2 in cancer of uterine cervix: a semiquantitative study of immunoreactivities using tissue array.

Wang PH, Ko JL, Tsai HT, Yang SF, Han CP, Lin LY, Chen GD.

Gynecol Oncol. 2008 Mar;108(3):533-42. doi: 10.1016/j.ygyno.2007.11.018. Epub 2008 Jan 4.

PMID:
18177928
Items per page

Supplemental Content

Write to the Help Desk